Author:
Yoon Esther Chaewon,Zhong Minghao
Publisher
Springer International Publishing
Reference45 articles.
1. Papanicolaou GN, Marshall VF. Urine sediment smears as a diagnostic procedure in cancers of the urinary tract. Science. 1945;101(2629):519–20. Epub 1945/05/18. doi: 10.1126/science.101.2629.519 . PubMed PMID: 17775845.
2. Sullivan PS, Chan JB, Levin MR, Rao J. Urine cytology and adjunct markers for detection and surveillance of bladder cancer. Am J Transl Res. 2010;2(4):412–40. Epub 2010/08/25. PubMed PMID: 20733951; PubMed Central PMCID: PMC2923865.
3. Mowatt G, Zhu S, Kilonzo M, Boachie C, Fraser C, Griffiths TR, et al. Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer. Health Technol Assess. 2010;14(4):1–331, iii–iv. Epub 2010/01/20. doi: 10.3310/hta14040 . PubMed PMID: 20082749.
4. Halachmi S, Linn JF, Amiel GE, Moskovitz B, Nativ O. Urine cytology, tumour markers and bladder cancer. Br J Urol. 1998;82(5):647–54. Epub 1998/12/05. PubMed PMID: 9839578.
5. Xie Q, Huang Z, Zhu Z, Zheng X, Liu J, Zhang M, et al. Diagnostic value of urine cytology in bladder cancer. A meta-analysis. Anal Quant Cytopathol Histopathol. 2016;38(1):38–44. Epub 2016/07/02. PubMed PMID: 27363065.